|
1
|
The cadherin-catenin adhesion system in signaling and cancer.
|
J Clin Invest
|
2002
|
3.23
|
|
2
|
Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
|
J Cell Biol
|
2003
|
3.09
|
|
3
|
L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
|
J Cell Biol
|
2005
|
2.39
|
|
4
|
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
|
Cancer Res
|
2007
|
2.26
|
|
5
|
Epithelial-mesenchymal transition and the invasive potential of tumors.
|
Trends Mol Med
|
2008
|
2.07
|
|
6
|
beta-Catenin signaling in biological control and cancer.
|
J Cell Biochem
|
2007
|
1.89
|
|
7
|
IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
|
Mol Biol Cell
|
2003
|
1.86
|
|
8
|
Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
|
Development
|
2004
|
1.58
|
|
9
|
Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
|
J Cell Sci
|
2002
|
1.50
|
|
10
|
Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
|
Genes Dev
|
2002
|
1.50
|
|
11
|
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
|
Cancer Res
|
2007
|
1.46
|
|
12
|
L1 cell adhesion molecule (L1CAM) in invasive tumors.
|
Cancer Lett
|
2009
|
1.25
|
|
13
|
SKI activates Wnt/beta-catenin signaling in human melanoma.
|
Cancer Res
|
2003
|
1.22
|
|
14
|
Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains.
|
J Biol Chem
|
2005
|
1.20
|
|
15
|
L1-CAM in cancerous tissues.
|
Expert Opin Biol Ther
|
2008
|
1.19
|
|
16
|
Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.
|
J Cell Sci
|
2010
|
1.15
|
|
17
|
Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics.
|
Oncogene
|
2004
|
1.13
|
|
18
|
Retracted
Regulation of p53: intricate loops and delicate balances.
|
Biochem Pharmacol
|
2002
|
1.05
|
|
19
|
The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.
|
Cancer Res
|
2005
|
0.97
|
|
20
|
L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
|
Mol Cancer Res
|
2010
|
0.95
|
|
21
|
PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription.
|
Cancer Res
|
2002
|
0.94
|
|
22
|
Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
|
Oncogene
|
2004
|
0.92
|
|
23
|
Targeting the active beta-catenin pathway to treat cancer cells.
|
Mol Cancer Ther
|
2006
|
0.86
|
|
24
|
c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
|
Cancer Res
|
2013
|
0.84
|
|
25
|
The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells.
|
J Cell Biochem
|
2009
|
0.84
|
|
26
|
Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer.
|
F1000 Biol Rep
|
2010
|
0.81
|